ConductScience.org, home

Paper973971

Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.

Lund-Johansen P. Br J Clin Pharmacol, 1976. Cited by 62 papers, by iCite.

Cite this record

ConductScience Library. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension. Papers, record 973971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/973971

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
3.88
iCite
Revised in PubMed
2019-05-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lund-Johansen PP

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtenololMajor topic
HemodynamicsMajor topic
HypertensionMajor topic
PropanolaminesMajor topic
Adult
Blood Pressure
Cardiac Output
Heart Rate
Humans
Male
Middle Aged
Oxygen Consumption
Physical Exertion
Vascular Resistance

Source PubMed

Download CSV of topics

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14149321Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension.Acta Med Scand1973https://conductscience.org/library/papers/4149321PubMed
24149691Preliminary report on the haemodynamic response of hypertensive patients treated with a beta blocker (ICI 66082).Acta Clin Belg1973https://conductscience.org/library/papers/4149691PubMed
34817079Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.Acta Med Scand1974https://conductscience.org/library/papers/4817079PubMed
44817078Hemodynamic changes at rest and during exercise in long-term clonidine therapy of essential hypertension.Acta Med Scand1974https://conductscience.org/library/papers/4817078PubMed
55458179Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide.Acta Med Scand1970https://conductscience.org/library/papers/5458179PubMed
64155970The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.Br J Pharmacol1974https://conductscience.org/library/papers/4155970PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
32395337Atenolol's Inferior Ability to Reduce Central vs Peripheral Blood Pressure Can Be Explained by the Combination of Its Heart Rate-Dependent and Heart Rate-Independent Effects.Int J Hypertens2020https://conductscience.org/library/papers/32395337PubMed
8776008The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocker therapy.Sports Med1996https://conductscience.org/library/papers/8776008PubMed
8097925
Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8097925PubMed
6125175How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125175PubMed
2866577Exercise performance and beta-blockade.Sports Med1985https://conductscience.org/library/papers/2866577PubMed
2076384Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2076384PubMed
1541316Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1541316PubMed
861129Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.Br J Clin Pharmacol1977https://conductscience.org/library/papers/861129PubMed
760749Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/760749PubMed
577181Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.Br J Clin Pharmacol1977https://conductscience.org/library/papers/577181PubMed
499314Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/499314PubMed
38096Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.Drugs1979https://conductscience.org/library/papers/38096PubMed
37872Possible significance of the pharmacological differentiation of beta-blockers for therapy of hypertension.Br J Clin Pharmacol1979https://conductscience.org/library/papers/37872PubMed
30514Beta-blockers in treatment of hypertension.Br Med J1978https://conductscience.org/library/papers/30514PubMed
26370The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26370PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/973971

GET https://conductscience.org/api/papers/v1/973971/authors